Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Virology

• Publication date

  2005-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VIROL.2004.12.036PMID 15721358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninfectious Recombinant Antigen for Detection of St. Louis Encephalitis Virus-Specific Antibodies in Serum by Enzyme-Linked Immunosorbent Assay

  2004cited by this paper
• Structure of the dengue virus envelope protein after membrane fusion

  2004cited by this paper
• Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.

  2003cited by this paper
• A ligand-binding pocket in the dengue virus envelope glycoprotein

  2003cited by this paper
• Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

  2003influential reference
• Role of the Transmembrane Domains of prM and E Proteins in the Formation of Yellow Fever Virus Envelope

  2003cited by this paper
• Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus

  2002cited by this paper
• Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine.

  2002cited by this paper
• A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.

  2001cited by this paper
• Flavivirus DNA vaccines: current status and potential.

  2001cited by this paper
• Flavivirus DNA Vaccines

  2001cited by this paper
• West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

  2001cited by this paper
• A Single Intramuscular Injection of Recombinant Plasmid DNA Induces Protective Immunity and Prevents Japanese Encephalitis in Mice

  2000cited by this paper
• Mapping of Functional Elements in the Stem-Anchor Region of Tick-Borne Encephalitis Virus Envelope Protein E

  1999cited by this paper
• A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.

  1999cited by this paper
• Virus Maturation by Budding

  1998cited by this paper
• Signal Peptidase Cleavage at the Flavivirus C-prM Junction: Dependence on the Viral NS2B-3 Protease for Efficient Processing Requires Determinants in C, the Signal Peptide, and prM

  1998cited by this paper
• Proteolytic activation of tick-borne encephalitis virus by furin

  1997cited by this paper
• Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

  1996cited by this paper
• Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus

  1996cited by this paper
• Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.

  1994cited by this paper
• Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies.

  1983cited by this paper
• Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

  1982cited by this paper
• 18 – Chemical and Antigenic Structure of Flaviviruses

  1980cited by this paper
• Segmented genome and nucleocapsid of La Crosse virus

  1976cited by this paper

• VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions

  2025cites this paper
• mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADE

  2025cites this paper
• An Integrative Approach to Rational Engineering of Dengue Virus-Like Particles

  2025cites this paper
• CHO cells for virus-like particle and subunit vaccine manufacturing.

  2024cites this paper
• FLAVIVIRUS CROSS-REACTIVITY: INSIGHTS INTO E-PROTEIN CONSERVANCY, PRE-EXISTING IMMUNITY, AND CO-INFECTION

  2024cites this paper
• Low-temperature culture enhances production of flavivirus virus-like particles in mammalian cells

  2024cites this paper
• Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

  2023cites this paper
• Virus-Like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development

  2022cites this paper
• Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform

  2022cites this paper
• Development of HEK-293 Cell Lines Constitutively Expressing Flaviviral Antigens for Use in Diagnostics

  2022cites this paper
• Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?

  2022cites this paper
• Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission

  2021cites this paper
• The key amino acids of E protein involved in early flavivirus infection: viral entry

  2021cites this paper
• Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

  2021cites this paper
• Cross-reactivity reduced dengue virus 2 vaccine has no cross-protection against heterotypic dengue viruses

  2020cites this paper
• A quantitative luciferase-based cell–cell fusion assay to measure four-serotype dengue virus E protein-triggered membrane fusion

  2020cites this paper
• Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae

  2019cites this paper
• Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.

  2019cites this paper
• Production and Biomedical Application of Flavivirus-like Particles.

  2019cites this paper
• MEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika

  2019cites this paper
• Current prevention and potential treatment options for dengue infection.

  2019cites this paper
• Cross-reactivity reduced dengue virus serotype 2 vaccine does not confer cross-protection against other serotypes of dengue viruses

  2018cites this paper
• Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies

  2018cites this paper
• A dengue monovalent vaccine with novel structure provides cross-protection against four serotypes of dengue virus

  2018cites this paper
• Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.

  2018cites this paper
• Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine

  2018cites this paper
• Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody

  2018cites this paper
• An epitope-resurfaced virus-like particle can induce broad neutralizing antibody against four serotypes of dengue virus

  2018cites this paper
• An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design

  2017influential citation
• Oleic acid Enhances Dengue Virus But Not Dengue Virus-Like Particle Production from Mammalian Cells

  2017cites this paper
• Evaluation of a Tetravalent DNA Vaccine against Dengue: Integrating Biochemical Studies on Dengue Virus Envelope Protein to a Domain-Based Antigen Design.

  2017cites this paper
• Virus like particle-based vaccines against emerging infectious disease viruses

  2016cites this paper
• Computational analysis of perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virus

  2016cites this paper
• Differential Diagnosis of Japanese Encephalitis Virus Infections with the Inbios JE Detect™ and DEN Detect™ MAC-ELISA Kits

  2016cites this paper
• Dengue Virus: Host-Pathogen Interactions and Emerging Role of DNA Vaccines

  2016cites this paper
• JOHNSON AND OTHERS DIFFERENTIAL DIAGNOSIS OF JE Differential Diagnosis of Japanese Encephalitis Virus Infections with the Inbios JE Detect TM and DEN Detect TM MAC-ELISA Kits

  2016cites this paper
• MMP 1-1 Generation and Characterization of DENV-1 / 2 EDIII Chimeric Virus like-Particles การสร้างและศึกษาคุณสมบัติของอนุภาคคล้ายไวรัสลูกผสม ระหว่างเช้ือไวรัสเด็งกี ่ชนิดที ่ 1 และ ชนิดที ่ 2

  2016cites this paper
• Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past

  2015cites this paper
• Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).

  2015cites this paper
• Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein

  2015cites this paper
• Next generation dengue vaccines: A review of the preclinical development pipeline.

  2015cites this paper
• A Recombinant Novirhabdovirus Presenting at the Surface the E Glycoprotein from West Nile Virus (WNV) Is Immunogenic and Provides Partial Protection against Lethal WNV Challenge in BALB/c Mice

  2014cites this paper
• Evolution of New Variants/Mutants of JE Virus, Its Effect on Neurovirulence, Antigenicity, Host Immune Responses and Disease Transmission in Endemic Areas

  2014cites this paper
• Medical Biotechnology Dengue: Possible strategies for molecular vaccine production

  2014cites this paper
• An optimized expression vector for improving the yield of dengue virus-like particles from transfected insect cells.

  2014cites this paper
• The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase

  2013cites this paper
• Research advances in plant-made flavivirus antigens.

  2012cites this paper
• Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

  2012cites this paper
• STUDYING THE ROLE OF HIGHLY CONSERVED RESIDUES IN THE STEM REGION OF DENV 1 ENVELOPE PROTEIN ON ASSEMBLY

  2012cites this paper
• Synergistic Interactions between the NS3hel and E Proteins Contribute to the Virulence of Dengue Virus Type 1

  2012cites this paper
• Transcriptional Regulation of the Interleukin-8 Promoter by Multiple Dengue Viral Proteins: A Dissertation

  2012cites this paper
• Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement

  2012cites this paper
• Dengue virus-like particles: construction and application

  2012cites this paper
• Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein.

  2011cites this paper
• Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts

  2011cites this paper
• Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice

  2011cites this paper
• A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein

  2011cites this paper
• Partial maturation: an immune-evasion strategy of dengue virus?

  2011cites this paper
• The Helical Domains of the Stem Region of Dengue Virus Envelope Protein Are Involved in both Virus Assembly and Entry

  2011cites this paper
• Next generation dengue vaccines: a review of candidates in preclinical development.

  2011cites this paper
• The Length of and Nonhydrophobic Residues in the Transmembrane Domain of Dengue Virus Envelope Protein Are Critical for Its Retention and Assembly in the Endoplasmic Reticulum

  2010cites this paper
• Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties

  2010cites this paper
• Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.

  2010cites this paper
• Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever

  2010cites this paper
• Dengue virus life cycle: viral and host factors modulating infectivity

  2010cites this paper
• Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins

  2009cites this paper
• Chapter 19 – Dengue

  2009cites this paper
• Evaluation of IgM antibody capture enzyme-linked immunosorbent assay kits for detection of IgM against Japanese encephalitis virus in cerebrospinal fluid samples.

  2009cites this paper
• The Infectious Agent

  2008cites this paper
• Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M Junction

  2008cites this paper
• A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles.

  2008influential citation
• Microcarrier culture of COS-1 cells producing Japanese encephalitis and dengue virus serotype 4 recombinant virus-like particles.

  2008influential citation
• A comparison of concentration methods applied to non-infectious flavivirus recombinant antigens for use in diagnostic serological assays.

  2007cites this paper
• Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein.

  2007cites this paper
• Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses

  2007cites this paper
• Development of novel vaccines for the concurrent immunisation against multiple dengue virus serotypes

  2006cites this paper
• Identification of epitopes on the Dengue virus type 4 envelope glycoprotein involved in neutralisation by antibodies

  2006cites this paper
• Dengue Diagnostics: proceedings of a joint tDR/WHo and PDVi workshop

  2005cites this paper
• Comparative Analysis of Immunoglobulin M (IgM) Capture Enzyme-Linked Immunosorbent Assay Using Virus-Like Particles or Virus-Infected Mouse Brain Antigens To Detect IgM Antibody in Sera from Patients with Evident Flaviviral Infections

  2005influential citation
• Dengue diagnostics: proceedings of an international workshop

  2005cites this paper
• Chemokine Induction by Dengue Virus Infection: Mechanisms and the Role of Viral Proteins: a Dissertation

  2005cites this paper
• Open Access Research Characterization of the Gxxxg Motif in the First Transmembrane Segment of Japanese Encephalitis Virus Precursor Membrane (prm) Protein

  year unknowncites this paper